Cargando…
Neoadjuvant Dovitinib in Early- and Intermediate-Stage Hepatocellular Carcinoma
This letter to the editor comments on recently reported results of a phase II study of dovitinib therapy for hepatocellular carcinoma
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732236/ https://www.ncbi.nlm.nih.gov/pubmed/35993601 http://dx.doi.org/10.1093/oncolo/oyac168 |
| Sumario: | This letter to the editor comments on recently reported results of a phase II study of dovitinib therapy for hepatocellular carcinoma |
|---|